GeoPharma receives FDA approval for dog drug
Pharmaceutical company GeoPharma, Inc. (Nasdaq: GORX) reported this morning that it received an approval from the U.S. Food and Drug Administration to begin producing Carprofen.
Carprofen, which is commonly marketed by Pfizer as “Rimadyl,” is a non-steroidal anti-inflammatory drug that is used by veterinarians for the relief of pain and inflammation associated with osteoarthritis in dogs.
Additionally, Carprofen is often used in the treatment of post-operative pain associated with soft tissue and orthopedic surgeries in dogs.
Shares of GeoPharma (GORX) were halted in pre-market trading.
